Sangamo Therapeutics, Inc. share price logo

Sangamo Therapeutics, Inc. Share Price

NASDAQ: SGMO

Small Cap

$0.50

-0.03

(-5.06%)

as on

Sangamo Therapeutics, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's High

    $0.5
    $0.53

    6.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.41
    $3.18
    downward going graph

    17.78%

    Downside

    535.80%

    Upside

    downward going graph

Sangamo Therapeutics, Inc. share price movements today

Previous Close
$0.53
Open
$0.52
Volume
4.3M
Day's Low - High
$0.5 - $0.53
52 Week Low - High
$0.41 - $3.18

Sangamo Therapeutics, Inc. Historical Returns

1 Month Return
-12.95 %
3 Month Return
+ 2.83 %
1 Year Return
-40.49 %
3 Year Return
-91.29 %
5 Year Return
0 %

Sangamo Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Sangamo Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$152.3M

EPS (TTM)

-0.4067

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.69

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-58.3M

Revenue (TTM)

81.7M

Profit Margin

-77.48%

Return On Equity TTM

182652000.00%

Sangamo Therapeutics, Inc. Stock Valuation

Track how Sangamo Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Sangamo Therapeutics, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Today (-0.69x)

September 15, 2025

Highest (-0.31x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -0.69x

Sangamo Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sangamo Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Sangamo Therapeutics, Inc. image
Sangamo Therapeutics, Inc.
BUY$152.3MNA-0.69-77.48%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B256.98%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.1B47.85%28.0731.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Sangamo Therapeutics, Inc. Stock including INR - Dollar returns

The Sangamo Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Sangamo Therapeutics, Inc. investment value today

Current value as on today

₹63,809

Returns

₹36,191

(-36.19%)

Returns from Sangamo Therapeutics, Inc. Stock

₹41,176 (-41.18%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Sangamo Therapeutics, Inc. Stock

Based on 15 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Sangamo Therapeutics, Inc.. Average target price of $4.1

Sangamo Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Sangamo Therapeutics, Inc..

What analysts predicted

87.8%UPSIDE

Target Price

$4.1

Current Price

$0.5

Analyzed by

15 Analysts

Target

$4.10

Sangamo Therapeutics, Inc. target price $4.1, a slight upside of 87.8% compared to current price of $0.5. According to 15 analysts rating.

Sangamo Therapeutics, Inc. Stock's Interest Amongst Investors

Search interest for Sangamo Therapeutics, Inc. Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-27% versus previous 30 day period

Sangamo Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
157
6
9
2
0
0
49
7
6
18
Gross Profit
154
2
-2
0
-2
-23
47
7
6
18
Operating Income
135
-123
-106
-62
-51
-37
10
-25
-29
-17
EBITDA
24
-66
-56
-57
-44
-33
12
-23
-27
-18
Interest Expense
113
-
-
113
-
-
-
-
-
-
Depreciation
5
6
7
3
2
2
2
2
1
1
Income Before Tax
21
-120
-102
-60
-48
-36
10
-23
-30
-19
Income Tax Expense
0
-6
1
0
0
0
0
0
0
0
Net Income
21
-114
-104
-60
-49
-36
10
-23
-30
-19
Net Profit Margin
13.38%
-1675.29%
-1108.35%
-2952.74%
-10205.61%
-10148.31%
21.60%
-309.84%
-475.33%
-109.18%

Sangamo Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
39
19
36
84
102
118
110
111
176
57
Gross Profit
39
19
36
84
102
118
110
111
154
57
Operating Income
-46
-72
-56
-77
-105
-129
-183
-201
-274
-103
EBITDA
-45
-71
-54
-74
-95
-116
-165
-180
-240
-89
Interest Expense
-
-
-
-
-
22
22
9
-
-
Depreciation
-
-
1
2
9
13
17
20
24
9
Income Before Tax
-46
-71
-54
-68
-95
-120
-177
-191
-262
-98
Income Tax Expense
-5
0
-1
8
-19
0
0
0
-5
0
Net Income
-40
-71
-54
-68
-75
-121
-178
-192
-257
-97
Net Profit Margin
-102.94%
-369.58%
-149.23%
-80.91%
-74.02%
-102.48%
-161.06%
-172.76%
-146.30%
-169.45%

Sangamo Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-114
-104
-60
-49
-36
10
-23
-30
-19
Operating Cash Flow
-60
-47
-50
-48
-26
11
-3
-26
-18
Investing Cash Flow
42
37
37
35
0
0
1
-
0
Financing Cash Flow
6
0
0
22
0
0
6
8
28
Change in Cash
-11
-10
-11
8
-27
12
2
-16
13

Sangamo Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-71
-54
-68
-95
-121
-178
-192
-257
-97
Operating Cash Flow
-65
11
37
-144
169
-233
-223
-224
-67
Investing Cash Flow
18
-80
-178
-59
-271
248
59
153
37
Financing Cash Flow
0
97
231
142
153
32
84
14
28
Change in Cash
-47
27
90
-61
50
47
-78
-55
-3

Global Institutional Holdings in Sangamo Therapeutics, Inc.

Funds
Holdings
Vanguard Group Inc
3.82%
Wasatch Advisors LP
2.8%
BlackRock Inc
2.22%
Renaissance Technologies Corp
1.29%
Geode Capital Management, LLC
0.93%
See all

Insights on Sangamo Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -30.59M → -19.98M (in $), with an average increase of 53.1% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 6.43M → 18.30M (in $), with an average increase of 64.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 214.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 116.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SGMO stock has moved down by -12.9%

About Sangamo Therapeutics, Inc.

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
OrganisationSangamo Therapeutics, Inc.
Headquarters501 Canal Blvd, Richmond, CA, United States, 94804
IndustryHealth Technology
CEODr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
E-voting on sharesClick here to vote

Key Management of Sangamo Therapeutics, Inc.

Name

Title

Ms. Prathyusha Duraibabu CPA, M.B.A.

Senior VP, CFO & Principal Accounting Officer

Mr. Gregory Davis Ph.D.

Head of Research & Technology

Mr. David Ojala

Scientist II - Discovery & Translational Research

Mr. Phillip Ramsey

Chief Technical Officer

Ms. Stephanie J. Seiler CLP

VP and Head of Business Development & Alliance Management

Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.

CEO, President & Director

Mr. Scott B. Willoughby

Senior VP, Chief Legal Officer & Corporate Secretary

Dr. Nathalie Dubois-Stringfellow Ph.D.

Senior VP & Chief Development Officer

Ms. Louise Wilkie

Head of Global Corporate Communications & Investor Relations

FAQs

What is Sangamo Therapeutics, Inc. share price today?

Sangamo Therapeutics, Inc. share price today is $0.5 as on at the close of the market. Sangamo Therapeutics, Inc. share today touched a day high of $0.53 and a low of $0.5.

What is the 52 week high and 52 week low for Sangamo Therapeutics, Inc. share?

Sangamo Therapeutics, Inc. share touched a 52 week high of $3.18 on and a 52 week low of $0.41 on . Sangamo Therapeutics, Inc. stock price today i.e. is closed at $0.5,which is 84.27% down from its 52 week high and 21.62% up from its 52 week low.

What is Sangamo Therapeutics, Inc.'s market capitalisation today?

Sangamo Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Sangamo Therapeutics, Inc. Stock (SGMO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sangamo Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sangamo Therapeutics, Inc. Shares that will get you 3.0000 shares as per Sangamo Therapeutics, Inc. share price of $0.5 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sangamo Therapeutics, Inc. Stock (SGMO) from India?

Indian investors can start investing in Sangamo Therapeutics, Inc. (SGMO) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Sangamo Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Sangamo Therapeutics, Inc. share’s latest price of $0.5 as on September 13, 2025 at 1:29 am IST, you will get 20.0000 shares of Sangamo Therapeutics, Inc.. Learn more about fractional shares .